-
AbbVie’s Allergan Aesthetics Launches Juvéderm VOLUX in China
•
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced the official market launch of its Juvéderm VOLUX dermal filler product in China. Juvéderm VOLUX is a hyaluronic acid-based product specifically designed for contouring the lower jaw area. It is used for injection onto the facial periosteum to enhance the…
-
AbbVie’s Allergan Aesthetics Wins NMPA Approval for Juvéderm Dermal Filler in China
•
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has secured marketing approval from China’s National Medical Products Administration (NMPA) for its Juvéderm product line, specifically the Juvéderm越致 dermal filler. This crosslinked sodium hyaluronate gel, which includes lidocaine for comfort during treatment, is designed for injection into the middle to deep…
-
Allergan Aesthetics’ Botox Secures New Indication for Masseter Muscle Protrusion in China
•
Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), has announced that it has received approval for a new indication from the National Medical Products Administration (NMPA) for its Botox (botulinum toxin type A) product. The drug is now approved for the temporary improvement of significant or very significant masseter muscle…
-
Allergan Aesthetics Launches SKINMEDICA in China, Targeting Booming Skincare Market
•
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced the market launch of its premium skincare product line, SKINMEDICA, in China. Known for its safety, efficacy, and clinical use backed by extensive medical research, SKINMEDICA is poised to offer Chinese consumers healthier and more confident skin solutions. This move…
-
AbbVie’s Allergan Aesthetics Secures NMPA Approval for Juvéderm VOLUMA with Lidocaine
•
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for Juvéderm VOLUMA with Lidocaine, expanding its indications to include nose augmentation procedures. Product Description and BenefitsJuvéderm VOLUMA with Lidocaine is a cross-linked sodium hyaluronate gel designed…
-
Pharmaron Secures UK Government Grant to Expand Viral Vector Manufacturing Facility
•
China-based Contract Development and Manufacturing Organization (CDMO) Pharmaron Beijing Co., Ltd (HKG: 3759, SHE: 300759) has announced the receipt of a substantial grant from the UK government’s Life Sciences Innovation Manufacturing Fund (LSMIF). The grant will facilitate the expansion of Pharmaron’s existing viral vector and DNA manufacturing facility in Liverpool,…
-
Allergan Aesthetics Partners with Sinopharm at CIIE for Aesthetic Medicine
•
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), has announced a partnership with Sinopharm Group Co., Ltd’s global procurement and supply chain service center at the 5th China International Import Expo (CIIE). The collaboration aims to deepen their partnership in several key areas, including product supply security, new product launches, and…
-
Allergan Aesthetics Launches Juvederm Volite in China’s Boao Lecheng
•
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), has announced the commercial launch of Juvederm Volite at the Arsmo (Hainan) Aesthetic Hospital in Boao Lecheng, China. The product follows the successful introduction of Juvederm Volux into the region under the “first pilot, first trial” policy, further expanding the company’s aesthetic portfolio…
-
Allergan Aesthetics Opens Shanghai Innovation Center for Medical Aesthetics
•
Allergan Aesthetics, a division of AbbVie, has officially opened its Shanghai innovation center, marking a significant expansion into the Chinese market. The center will focus on medical aesthetics education and product clinical application training, further solidifying Allergan Aesthetics’ commitment to advancing the field of aesthetic medicine. Center’s Focus and ObjectivesThe…
-
Bloomage Biotech Terminates Medytox Pact Over Botox Supply Issues
•
China-based Bloomage Biotech (SHA: 688363) announced that its wholly owned subsidiary, Gentix Limited, has issued a lawyer’s letter to South Korea-headquartered Medytox Inc. on July 29, 2022, seeking to terminate the agreement between the two companies related to Botox and other medical aesthetics products. The move comes after no products…
-
AbbVie’s Allergan Aesthetics CoolAdvantage Applicator Wins NMPA Approval
•
US-based AbbVie’s Allergan Aesthetics announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its CoolAdvantage applicator series, alongside its official market launch in China. Technology and FeaturesCoolSculpting utilizes a non-surgical process called cryolipolysis to target and reduce subcutaneous fat by cooling fat cells to…
